| Product NDC: | 44087-8822 |
| Proprietary Name: | Rebif |
| Non Proprietary Name: | interferon beta-1a |
| Active Ingredient(s): | & nbsp; interferon beta-1a |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 44087-8822 |
| Labeler Name: | EMD Serono, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103780 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20041217 |
| Package NDC: | 44087-8822-1 |
| Package Description: | 1 KIT in 1 CARTON (44087-8822-1) * .2 mL in 1 SYRINGE, GLASS * .5 mL in 1 SYRINGE, GLASS |
| NDC Code | 44087-8822-1 |
| Proprietary Name | Rebif |
| Package Description | 1 KIT in 1 CARTON (44087-8822-1) * .2 mL in 1 SYRINGE, GLASS * .5 mL in 1 SYRINGE, GLASS |
| Product NDC | 44087-8822 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | interferon beta-1a |
| Dosage Form Name | KIT |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20041217 |
| Marketing Category Name | BLA |
| Labeler Name | EMD Serono, Inc. |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |